In France, Sebastian Enault has joined Deinove’s executive committee as a business development director. In the role, Enault will be responsible for expanding and promoting the company’s portfolio of programs and products in the healthcare and cosmetics markets, while also contributing to its first cosmetics ingredients launch scheduled for next year. Prior to joining Deinove, Enault led start-up company Eligo Bioscience’s business development unit. Earlier in his career, Enault spent ten years managing biopharmaceutical company MedinCell’s business development unit and also conducted pharmacology research in various facilities including the Faculty of Pharmacy in Marseille, Cancer Research UK, and Harvard Medical School.
Deinove is a biotechnology company that discovers, develops, and produces high-value compounds from rare bacteria.